Galecto Is Maintained at Outperform by Oppenheimer
Galecto Analyst Ratings
Oppenheimer Maintains Galecto(GLTO.US) With Buy Rating, Cuts Target Price to $10
Oppenheimer Sticks to Its Buy Rating for Galecto (GLTO)
Galecto Analyst Ratings
Oppenheimer Remains a Buy on Galecto (GLTO)
H.C. Wainwright Sticks to Their Hold Rating for Galecto (GLTO)
Analysts Offer Insights on Healthcare Companies: Galecto (GLTO), Encompass Health (EHC) and Caribou Biosciences (CRBU)
Galecto Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Galecto (GLTO), Amylyx Pharmaceuticals Inc (AMLX)
HC Wainwright & Co. Maintains Buy on Galecto, Lowers Price Target to $2
Galecto Analyst Ratings
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Galecto (GLTO) and Cardinal Health (CAH)
Galecto Analyst Ratings
Galecto (GLTO) Receives a Buy From H.C. Wainwright
HC Wainwright & Co. Reiterates Buy on Galecto, Maintains $12 Price Target
Galecto Analyst Ratings
Oppenheimer Initiates Coverage On Galecto With Outperform Rating, Announces Price Target of $12
HC Wainwright & Co. Reiterates Buy on Galecto, Maintains $12 Price Target
Analysts Offer Insights on Healthcare Companies: Galecto (GLTO), Bioxcel Therapeutics (BTAI) and Wave Life Sciences (WVE)